# Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections

> **NCT03162458** · PHASE3 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 142 (actual)

## Conditions studied

- Acute Upper Respiratory Infections

## Interventions

- **DRUG:** Anaferon for children (liquid dosage form)
- **DRUG:** Placebo (liquid dosage form)

## Key facts

- **NCT ID:** NCT03162458
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-22
- **Primary completion:** 2015-04-29
- **Final completion:** 2015-04-29
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2018-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03162458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03162458, "Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory Infections". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03162458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*